China's Fast Track Process For Medical Devices Growing With 46 Products Admitted So Far
This article was originally published in SRA
The China Food and Drug Administration's fast track process for evaluating innovative medical devices is growing at a steady pace with 46 products admitted for evaluation so far, of which 17 were submitted in 2014 (of which six have been approved) and 29 in 2015 (of which two have been approved). The fast track route was launched on March 1, 20141.
You may also be interested in...
Medical device companies operating in China are still looking for clearer guidance that will help them make the most of the wide-ranging regulatory reforms introduced in the country since 2014.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.